Clinical curative effect of neoadjuvant chemotherapy combined with immunotherapy and its impact on immunological function and the expression of ER, PR, HER-2 & SATB1 in HER-2-Positive breast cancer patients.

Chen, Zhi; Sang, Mei-Xiang; Geng, Cui-Zhi; Hao, Wei; Jia, Hui-Qun

Chen, Zhi; Sang, Mei-Xiang; Geng, Cui-Zhi; Hao, Wei; Jia, Hui-Qun.

Afiliação

Chen Z; Zhi Chen, Department of Anesthesiology, The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050017, China.
Sang MX; Mei-xiang Sang, Research Center and Tumor Research Institute, The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050017, China.
Geng CZ; Cui-zhi Geng, Breast Disease Diagnostic and Therapeutic Center, The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050017, China.
Hao W; Wei Hao, Baoding Third Central Hospital, Baoding, Hebei, 071051 China.
Jia HQ; Hui-qun Jia, Department of Anesthesiology, The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050017, China.

Pak J Med Sci ; 38(3Part-I): 553-559, 2022.

Article em En | MEDLINE | ID: mdl-35480523